US administration rolls back transgender health protections
The U.S. Department of Health and Human Services announced Friday that it will amend the Affordable Care Act’s Section 1557, removing language that previously extended “sex” discrimination protections to include gender identity.
Rule change narrows definition of sex
The new regulation, slated to take effect in August, reverts to a “plain meaning” interpretation of the word “sex,” limiting it to male or female as defined by biology. The 2016 guidance under the previous administration had clarified that “sex” also covered gender identity—an individual’s internal sense of gender, which may differ from the sex assigned at birth.
Under the updated rule, health programs and activities funded by the federal government will no longer be required to consider gender identity when providing services. The HHS statement emphasizes that the law already prohibits discrimination based on race, color, national origin, sex, age, or disability, and the revision is presented as a clarification rather than an expansion of those categories.
Officials cite cost savings
Roger Severino, director of the Office for Civil Rights at HHS, said the rule will save about $2.9 billion over five years, primarily by eliminating the need to produce multilingual informational materials. “Now more than ever, Americans do not want billions of dollars in ineffective regulatory burdens raising the costs of their healthcare,” he said.
Severino added that the administration aims to reduce “unnecessary costs that add economic burdens to patients, providers, and insurers alike.” The claim rests on the assumption that the removed provisions required additional administrative work and translation services.
The Department’s press release asserts that the change will streamline compliance and reduce paperwork for health providers, though it does not detail how the savings will be measured.
Related: Imagined Futures Appear Brighter Than Current Reality
According to the Williams Institute at UCLA School of Law, roughly 1.4 million adults in the United States identify as transgender, a figure that may be an underestimate. Research published in Current Opinion in Endocrinology, Diabetes and Obesity indicates that stigma and discrimination already limit access to care for many transgender patients.
World Health Organization guidance notes that “transphobia and discrimination are major barriers to healthcare access,” and stresses the importance of gender‑affirmative services, which can include hormonal therapy and surgeries that align patients’ bodies with their gender identity.
Transgender‑rights advocates have reacted sharply. Mara Keisling, executive director of the National Center for Transgender Equality, called the regulation “hateful and cruel,” arguing that it will impede access to essential medical services.
Keisling’s organization warned that the timing of the rule, amid the ongoing COVID‑19 pandemic, could exacerbate health disparities for an already vulnerable population. The group plans to challenge the rule through administrative appeals and possible litigation.
Legal experts note that Section 1557 has been the subject of multiple lawsuits since its inception, and the current amendment could trigger fresh challenges in federal courts. The outcome may hinge on how courts interpret “sex” under the Civil Rights Act and whether the change is deemed consistent with the statute’s broader anti‑discrimination purpose.
For now, health providers receiving federal funds must align their policies with the revised definition, which could lead to varied implementation across states. Some facilities have already signaled they will continue to uphold broader protections voluntarily, while others may adjust intake forms and staff training to reflect the narrower scope.
